Deuterium-labeled phylloquinone fed to α-tocopherol-injected rats demonstrates sensitivity of low phylloquinone-containing tissues to menaquinone-4 depletion

Molecular Nutrition and Food Research

Volumn 58, Issue 8, 2014, Pages 1610-1619

  Farley, Sherry M ^a,b   Leonard, Scott W ^a   Stevens, Jan F ^a,b   Traber, Maret G ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

5C and 7C aglycones; Bile; Brain; CEHC; CYP4F2; Heart; Urine

Indexed keywords

ALPHA TOCOPHEROL; DEUTERIUM; FARNOQUINONE; MENATETRENONE; PHYTOMENADIONE; VITAMIN;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; BIOTRANSFORMATION; BLOOD; BRAIN; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; KIDNEY; LIVER; MALE; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VITAMIN K DEFICIENCY;

ALPHA-TOCOPHEROL; ANIMALS; BIOTRANSFORMATION; BRAIN; DEUTERIUM; INJECTIONS, SUBCUTANEOUS; KIDNEY; LIVER; MALE; NEURONS; ORGAN SPECIFICITY; RATS, SPRAGUE-DAWLEY; VITAMIN K 1; VITAMIN K 2; VITAMIN K DEFICIENCY; VITAMINS;

EID: 84905393618     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300659     Document Type: Article

References (67)

1. Moshfegh, A., Goldman, J., Cleveland, L., What we eat in America, NHANES 2001-2002: usual nutrient intakes from food compared to dietary reference intakes. U.S. Department of Agriculture, Agricultural Research Service, 2005.
2. Bailey, R. L., Fulgoni, V. L., Keast, D. R., Dwyer, J. T., Examination of vitamin intakes among US adults by dietary supplement use. J. Acad. Nutr. Dietetics 2012, 112, 657-663.
3. Miller, A., Popular but dangerous: 3 vitamins that can hurt you if you take a vitamin pill, these warnings probably apply to you. U.S. News & World Report LP, 2012, Available from: http://health.usnews.com/health-news/diet-fitness/articles/2012/02/24/popular-but-dangerous-3-vitamins-that-can-hurt-you. Accessed: November 10, 2013.
4. Miller, E. R., Paston-Barriuso, R., Dalal, D., Riemersma, R. A., et al., Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 2005, 142, 37-46.
5. Myung, S. K., Ju, W., Cho, B., Oh, S. W. et al., Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013, 346, f10.
6. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., Gluud, C., Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2012, 3, CD007176.
7. Lee, I. M., Cook, N. R., Gaziano, J. M., Gordon, D. et al., Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294, 56-65.
8. Lonn, E., Bosch, J., Yusuf, S., Sheridan, P. et al., Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293, 1338-1347.
9. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T. et al., Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300, 2123-2133.
10. Schurks, M., Glynn, R. J., Rist, P. M., Tzourio, C. et al., Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010, 341, c5702.
11. Wheldon, G. H., Bhatt, A., Keller, P., Hummler, H., d, 1-Alpha-tocopheryl acetate (vitamin E): a long term toxicity and carcinogenicity study in rats. Int. J. Vitam. Nutr. Res. 1983, 53, 287-296.
12. Abdo, K. M., Rao, G., Montgomery, C. A., Dinowitz, M. et al., Thirteen-week toxicity study of d-alpha-tocopheryl acetate (vitamin E) in Fischer 344 rats. Food Chem. Toxicol. 1986, 24, 1043-1050.
13. Takahashi, O., Ichikawa, H., Sasaki, M., Hemorrhagic toxicity of d-alpha-tocopherol in the rat. Toxicology 1990, 63, 157-165.
14. Frank, J., Weiser, H., Biesalski, H. K., Interaction of vitamins E and K: effect of high dietary vitamin E on phylloquinone activity in chicks. Int. J. Vitam. Nutr. Res. 1997, 67, 242-247.
15. Helson, L., The effect of intravenous vitamin E and menadiol sodium diphosphate on vitamin K dependent clotting factors. Thromb. Res. 1984, 35, 11-18.
16. Woolley, D. W., Biological antagonisms between metabolically important compounds and their structural analogs. Harvey Lect. 1945, 41, 189-215.
17. March, B. E., Wong, E., Seier, L., Sim, J. et al., Hypervitaminosis E in the chick. J. Nutr. 1973, 103, 371-377.
18. Food and Nutrition Board, Institute of Medicine, Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, National Academy Press, Washington 2000.
19. Booth, S. L., Golly, I., Sacheck, J. M., Roubenoff, R. et al., Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am. J. Clin. Nutr. 2004, 80, 143-148.
20. Glynn, R. J., Ridker, P. M., Goldhaber, S. Z., Zee, R. Y. et al., Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation 2007, 116, 1497-1503.
21. Shearer, M. J., Newman, P., Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J. Lipid Res. 2014, 55, 345-362.
22. Nakagawa, K., Hirota, Y., Sawada, N., Yuge, N. et al., Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature 2010, 468, 117-121.
23. Thijssen, H. H., Vervoort, L. M., Schurgers, L. J., Shearer, M. J., Menadione is a metabolite of oral vitamin K. Br. J. Nutr. 2006, 95, 260-266.
24. Hirota, Y., Tsugawa, N., Nakagawa, K., Suhara, Y. et al., Menadione (vitamin K3) is a catabolic product of oral phylloquinone (vitamin K1) in the intestine and a circulating precursor of tissue menaquinone-4 (vitamin K2) in rats. J. Biol. Chem. 2013, 288, 33071-33080.
25. Lamon-Fava, S., Sadowski, J. A., Davidson, K. W., O'Brien, M. E. et al., Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans. Am. J. Clin. Nutr. 1998, 67, 1226-1231.
26. Erkkila, A. T., Lichtenstein, A. H., Dolnikowski, G. G., Grusak, M. A. et al., Plasma transport of vitamin K in men using deuterium-labeled collard greens. Metabolism 2004, 53, 215-221.
27. Okano, T., Shimomura, Y., Yamane, M., Suhara, Y. et al., Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J. Biol. Chem. 2008, 283, 11270-11279.
28. Horie-Inoue, K., Inoue, S., Steroid and xenobiotic receptor mediates a novel vitamin K2 signaling pathway in osteoblastic cells. J. Bone Miner. Metab. 2008, 26, 9-12.
29. Fredericks, W. J., McGarvey, T., Wang, H., Zheng, Y. et al., The TERE1 protein interacts with mitochondrial TBL2: regulation of trans-membrane potential, ROS/RNS and SXR target genes. J. Cell. Biochem. 2013, 114, 2170-2187.
30. McGarvey, T. W., Nguyen, T., Tomaszewski, J. E., Monson, F. C. et al., Isolation and characterization of the TERE1 gene, a gene down-regulated in transitional cell carcinoma of the bladder. Oncogene 2001, 20, 1042-1051.
31. Mugoni, V., Postel, R., Catanzaro, V., De Luca, E. et al., Ubiad1 is an antioxidant enzyme that regulates eNOS activity by CoQ10 synthesis. Cell 2013, 152, 504-518.
32. Nickerson, M. L., Bosley, A. D., Weiss, J. S., Kostiha, B. N. et al., The UBIAD1 prenyltransferase links menaquinone-4 [corrected] synthesis to cholesterol metabolic enzymes. Hum. Mutat. 2013, 34, 317-329.
33. Fredericks, W. J., Sepulveda, J., Lai, P., Tomaszewski, J. E. et al., The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes. Oncotarget 2013, 4, 1075-1092.
34. Ferland, G., The discovery of vitamin K and its clinical applications. Ann. Nutr. Metab. 2012, 61, 213-218.
35. Buitenhuis, H. C., Soute, B. A., Vermeer, C., Comparison of the vitamins K1, K2 and K3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochim. Biophys. Acta 1990, 1034, 170-175.
36. Rishavy, M. A., Berkner, K. L., Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv. Nutr. 2012, 3, 135-148.
37. Vermeer, C., Vitamin K: the effect on health beyond coagulation-an overview. Food Nutr. Res. 2012, 56, doi: 10.3402/fnr.v56i0.5329.
38. Rishavy, M. A., Hallgren, K. W., Wilson, L. A., Usubalieva, A. et al., The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation. J. Biol. Chem. 2013, 288, 31556-31566.
39. Wu, S., Liu, S., Davis, C. H., Stafford, D. W. et al., A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle. J. Theor. Biol. 2011, 279, 143-149.
40. Suhara, Y., Murakami, A., Nakagawa, K., Mizuguchi, Y. et al., Comparative uptake, metabolism, and utilization of menaquinone-4 and phylloquinone in human cultured cell lines. Bioorg. Med. Chem. 2006, 14, 6601-6607.
41. Chatrou, M. L., Reutelingsperger, C. P., Schurgers, L. J., Role of vitamin K-dependent proteins in the arterial vessel wall. Hamostaseologie 2011, 31, 251-257.
42. Traber, M. G., Atkinson, J., Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 2007, 43, 4-15.
43. Traber, M. G., Mechanisms for the prevention of vitamin E excess. J. Lipid Res. 2013, 54, 2295-2306.
44. McDonald, M. G., Rieder, M. J., Nakano, M., Hsia, C. K. et al., CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol. Pharmacol. 2009, 75, 1337-1346.
45. Edson, K. Z., Prasad, B., Unadkat, J. D., Suhara, Y. et al., Cytochrome P450-dependent catabolism of vitamin K: omega-hydroxylation catalyzed by human CYP4F2 and CYP4F11. Biochemistry 2013, 52, 8276-8285.
46. Harrington, D. J., Booth, S. L., Card, D. J., Shearer, M. J., Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 2007, 137, 1763-1768.
47. Sontag, T. J., Parker, R. S., Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 2002, 277, 25290-25296.
48. Sontag, T. J., Parker, R. S., Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase. J. Lipid Res. 2007, 48, 1090-1098.
49. Jiang, Q., Natural forms of vitamin E: metabolism, antioxidant and anti-inflammatory activities and the role in disease prevention and therapy. Free Radic. Biol. Med. 2014, 72C, 76-90.
50. Farley, S. M., Leonard, S. W., Labut, E. M., Raines, H. F. et al., Vitamin E decreases extra-hepatic menaquinone-4 concentrations in rats fed menadione or phylloquinone. Mol. Nutr. Food Res. 2012, 56, 912-922.
51. Farley, S. M., Leonard, S. W., Taylor, A. W., Birringer, M. et al., omega-Hydroxylation of phylloquinone by CYP4F2 is not increased by alpha-tocopherol. Mol. Nutr. Food Res. 2013, 57, 1785-1793.
52. Podda, M., Weber, C., Traber, M. G., Packer, L., Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols and ubiquinones. J. Lipid Res. 1996, 37, 893-901.
53. Leonard, S. W., Traber, M. G., Measurement of the vitamin E metabolites, carboxyethyl hydroxychromans (CEHCs), in biological samples. Curr. Protoc. Toxicol. 2006, 29, 7.8.1-7.8.12.
54. Li, Y. J., Luo, S. C., Lee, Y. J., Lin, F. J. et al., Isolation and identification of alpha-CEHC sulfate in rat urine and an improved method for the determination of conjugated alpha-CEHC. J. Agric. Food Chem. 2008, 56, 11105-11113.
55. Al Rajabi, A., Booth, S. L., Peterson, J. W., Choi, S. W. et al., Deuterium-labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats. J. Nutr. 2012, 142, 841-845.
56. Vatassery, G. T., Brin, M. F., Fahn, S., Kayden, H. J. et al., Effect of high doses of dietary vitamin E upon the concentrations of vitamin E in several brain regions, plasma, liver and adipose tissue of rats. J. Neurochem. 1988, 51, 621-623.
57. Ingold, K. U., Burton, G. W., Foster, D. O., Hughes, L. et al., Biokinetics of and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat. Lipids 1987, 22, 163-172.
58. Schurgers, L. J., Vermeer, C., Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim. Biophys. Acta 2002, 1570, 27-32.
59. Tovar, A., Ameho, C. K., Blumberg, J. B., Peterson, J. W. et al., Extrahepatic tissue concentrations of vitamin K are lower in rats fed a high vitamin E diet. Nutr. Metab. 2006, 3, 29.
60. Thijssen, H. H., Drittij-Reijnders, M. J., Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone-4. Br. J. Nutr. 1994, 72, 415-425.
61. Thijssen, H. H., Drittij-Reijnders, M. J., Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4. Br. J. Nutr. 1996, 75, 121-127.
62. Niemeier, A., Niedzielska, D., Secer, R., Schilling, A. et al., Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function. Bone 2008, 43, 230-237.
63. Bharadwaj, K. G., Hiyama, Y., Hu, Y., Huggins, L. A. et al., Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake. J. Biol. Chem. 2010, 285, 37976-37986.
64. Goldberg, I. J., Trent, C. M., Schulze, P. C., Lipid metabolism and toxicity in the heart. Cell Metab. 2012, 15, 805-812.
65. Reboul, E., Borel, P., Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog. Lipid Res. 2011, 50, 388-402.
66. Podszun, M. C., Grebenstein, N., Spruss, A., Schlueter, T. et al., Dietary alpha-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs. J. Nutr. Biochem. 2014, 25, 573-579.
67. Venugopal, S. K., Devaraj, S., Jialal, I., RRR-alpha-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition of tyrosine kinase (Tyk2). Atherosclerosis 2004, 175, 213-220.